ijms-logo

Journal Browser

Journal Browser

Roles of Extracellular Vesicles in Cerebrovascular Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 1393

Special Issue Editor


E-Mail Website
Guest Editor
Department of Biomedical Sciences, Joan C Edwards School of Medicine, Marshall University, Huntington, WV 25755, USA
Interests: EV function; EV-based therapy for cerebrovascular disease; stroke; demantia; hypertension, aging

Special Issue Information

Dear Colleagues,

Cerebrovascular disease is a major contributor to later-life dementia, accounting for up to 20% of cases of dementia. A sedentary lifestyle, hypertension, diabetes, and aging are major risk factors for cerebrovascular diseases. Extracellular vesicles (EVs) are extracellular nanovesicles released by virtually cell lineages. In recent decades, much attention has been devoted to EVs as novel carriers of bioactive molecules such as proteins and genetic materials to influence the functions of cells/tissues nearby and distant. Because of their ability to cross the brain-blood barrier, EVs have the potential to serve as biomarkers and therapeutic carriers to deliver molecules into the brain. Emerging evidence indicates that circulating and brain-derived EVs might play a role in cerebrovascular diseases. However, how the circulating and/or brain-derived EVs secreted in physiological and pathological microenvironments differently affect the interactions of brain cells is largely unknown. In this regard, we invite investigators to contribute original research articles and reviews that stimulate the continuing efforts to understand EVs' roles and potential applications in cerebrovascular diseases such as stroke and hypertension- and aging-related dementia.

As the Guest Editor of this Special Issue, I hope this collection will be a useful reference for understanding EVs' roles and potential application in cerebrovascular diseases and their comorbidities.

We look forward to receiving your contributions.

Dr. Jinju Wang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • exosomes
  • cerebrovascular disease
  • stroke
  • hypertension-related dementia
  • aging-related dementia

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

18 pages, 639 KiB  
Review
Extracellular Vesicles in Neurodegenerative Diseases: An Update
by Smara Sigdel, Sabrina Swenson and Jinju Wang
Int. J. Mol. Sci. 2023, 24(17), 13161; https://doi.org/10.3390/ijms241713161 - 24 Aug 2023
Viewed by 1188
Abstract
Neurodegenerative diseases affect millions of people worldwide. The likelihood of developing a neurodegenerative disease rises dramatically as life expectancy increases. Although it has drawn significant attention, there is still a lack of proper effective treatments for neurodegenerative disease because the mechanisms of its [...] Read more.
Neurodegenerative diseases affect millions of people worldwide. The likelihood of developing a neurodegenerative disease rises dramatically as life expectancy increases. Although it has drawn significant attention, there is still a lack of proper effective treatments for neurodegenerative disease because the mechanisms of its development and progression are largely unknown. Extracellular vesicles (EVs) are small bi-lipid layer-enclosed nanosized particles in tissues and biological fluids. EVs are emerging as novel intercellular messengers and regulate a series of biological responses. Increasing evidence suggests that EVs are involved in the pathogenesis of neurodegenerative disorders. In this review, we summarize the recent findings of EVs in neurodegenerative diseases and bring up the limitations in the field. Full article
(This article belongs to the Special Issue Roles of Extracellular Vesicles in Cerebrovascular Diseases)
Show Figures

Figure 1

Back to TopTop